Skip to main content

Lung Cancer - A Look at the Numbers

It is a known fact that lung cancer is the second leading cause of death and the biggest cause of cancer deaths in both sexes in the West. It accounts for about 30% of all deaths from cancer.

The unfortunate reality is that many of those deaths could have been prevented -- fully 85% of all lung cancers are caused by smoking. This includes those who breathe in second-hand smoke from others in the vicinity. If everyone were to give up smoking, the incidence of lung cancer would drop dramatically.

After smoking, radon exposure is the second most common cause of lung cancer in America. The US Environmental Protection Agency estimates that about 21,000 deaths are caused every year by radon exposure.

Among various ethnic groups, the incidence of lung cancer is highest among African Americans. This is because of a high cultural propensity among this group to take up the smoking habit.

This is also one of the deadliest forms of cancer around. To give some comparative statistics, the five-year survival rate from colon cancer is 62% and that from breast cancer 87%. The corresponding figure for prostate cancer is 98%. In sharp contrast, the five-year survival rate for lung cancer is a low 15%.

One reason for this low survival rate is that lung cancer tends to be diagnosed at a very late stage in its cycle -- typically during stage 3 or stage 4. By that time, the cancer has spread to other parts of the body and has affected many vital organs. This significantly reduces the probability of survival.

There is a prevailing myth that a smoker's lungs will return to normal fifteen years after he stops smoking and at that point, his chances of developing lung cancer are the same as that for a non-smoker. The reality is that a smoker's lungs never become completely normal again. However, it is true that his chances of getting lung cancer drop off as time passes, although it probably never drops to the level of a person who has remained smoke-free all his life.

This is borne out by the fact that while existing smokers make up about 40% of all new cases of lung cancer, former smokers account for fully 50% of such cases.

Studies indicate that former smokers have about 9 times greater chances of dying from lung cancer as compared to those who never smoked. Current smokers are said to be 23 times more likely to die from this disease than people who never smoked.

The numbers are slightly lower for women -- former women smokers have 5 times the chances of dying from lung cancer when compared to never smokers. And current smokers are 13 times as likely to die of this illness.

It is obvious that prevention is the best policy when it comes to lung cancer. And the way to prevent this disease is to not smoke at all or at least, to give up smoking at the earliest.

Popular posts from this blog

Alternative Pain Therapy for Breast, Prostate and Lung Cancer

Alternative Pain Therapy for Breast, Prostate and Lung Cancer MIAMI--(Healthcare Sales & Marketing Network)-- Bio-Nucleonics? lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron?, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer. Strontium Chloride Sr-89 Injection USP (Strontium-89) is a radioactive pharmaceutical injection to relieve bone pain in patients with painful skeletal metastases. In the body, Strontium acts similar to calcium and is preferentially taken up in osteoblastic tissue while the unabsorbed isotope is excreted in the urine the first 2 to 3 days following injection, clearing rapidly from the blood and selectively localizing in bone mineral. Uptake of strontium by bone occurs preferentially in sites of active osteogenesis; thus primary bone tumors and areas of metastatic involvement (blastic lesions) can accumulate significa...

Analysis: Life saving lung cancer test to set off cost debate

By Bill Berkrot NEW YORK | Wed Jun 29, 2011 6:07pm EDT NEW YORK (Reuters) - A landmark study showing that routine lung screening of heavy smokers and former smokers using low dose CT scans could save thousands of lives is sure to set off a fierce debate about the cost of such testing on an overburdened healthcare system. The U.S. National Cancer Institute studied more than 53,000 people between the ages of 55 and 74 deemed at high risk of developing lung cancer. It found that screening with the three-dimensional X-rays cut deaths by 20 percent. Details of the study and a discussion of its implications were published on Wednesday in the New England Journal of Medicine, lending additional weight to initial findings that were released in November. The discussion noted that radiologists using more advanced CT equipment than was available for the study could lead to an even larger reduction in lung cancer deaths. At the same time, the potential for many more false positive results could ri...

What Is Relay For Life About And Why Is It Important?

The Relay for Life idea began with one person wanting to fight cancer. In 1985 Dr. Gordy Klatt decided to run and walk around a track for 24 hours as an effort to raise money for the American Cancer Society. His idea has caught on big time and now more than 3.5 million people take part in the annual Relay for Life in over 5,000 towns and cities in the United States as well as in 20 other countries around the globe. To quote the Relay for Life site, it's a "global phenomenon" and it raises much needed funds as well as a national awareness for cancer and the research into a cure. During this first year Dr. Klatt ran over 83 miles at the University of Puget Sound, Tacoma, Washington. As Dr. Klatt walked and ran his laps family and friends participated by donating $25 to walk and run with him for half an hour. This initial effort by Dr. Klatt produced $27,000 of funds that were put to cancer research to fight this disease. Every Relay For Life has many similarities although ...